1. RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma
   Xiaohong Jin et al, 2020, International Immunopharmacology CrossRef
2. Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study
   Guangrong Lu et al, 2019, Frontiers in Neurology CrossRef
3. Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab
   Guangrong Lu et al, 2022, Journal of Neuro-Oncology CrossRef